AI IN LIFE SCIENCE · CHINA FIRST, GLOBAL VIEW

See where AI is actually working across the life science value chain.

Agents collect and classify AI use cases from public sources every day. Reviewers approve them. You get cited cases, process-level analysis and status reports for pharma and medtech.

Sign inHow it worksPrivate workspace. Accounts are by invitation only.
J&J Innovative MedicineJ&J MedTech

WHAT YOU GET

One evidence base, four ways to use it

From a single cited case to an industry-level view, everything comes from the same reviewed evidence.

Use case library

AI use cases from the last 12 months, China and global, each with its source, stage and a quote from the page.

Domains & processes

Cases mapped to 18 business domains aligned with J&J terminology, with trends, commonalities, differentiators and a point of view.

Industry status

Versioned status reports for JJIM, JJMT or both. An agent drafts each week; a reviewer approves each edition.

Weekly brief

Accepted cases by domain, rule changes, open consultations and company moves for the week, with sources.

HOW IT WORKS

Agents do the reading. People make the calls.

  1. Collect

    Agents read approved public sources: regulators, company newsrooms and trade press. They respect robots.txt and keep only short quotes from press.

  2. Classify

    A classification agent maps each case to the process taxonomy and the business unit, and cites the text it relied on.

  3. Review

    A named reviewer accepts, corrects or rejects every draft. Nothing counts until a person approves it.

  4. Analyse & report

    Analyst and report agents draft per-domain analysis and status reports from approved cases only, for review.

HOW WE KEEP IT HONEST

Evidence before opinion

Every statement has a source
Claims link to the page they came from. Counts are computed from the data, never written by a model.
Agents draft, people approve
Drafts stay labelled as drafts until a reviewer approves them.
Public information only
Public sources are never presented as internal facts about any company.
Absence is not evidence
A missing case means it was not found or not yet reviewed, not that it does not exist.